Mesenchymal Stem Cells Promote Metastasis of Lung Cancer Cells by Downregulating Systemic Antitumor Immune Response
Open Access
- 1 January 2017
- journal article
- research article
- Published by Wiley in Stem Cells International
- Vol. 2017, 1-11
Abstract
Since majority of systemically administered mesenchymal stem cells (MSCs) become entrapped within the lungs, we used metastatic model of lung cancer, induced by intravenous injection of Lewis lung cancer 1 (LLC1) cells, to investigate the molecular mechanisms involved in MSC-mediated modulation of metastasis. MSCs significantly augmented lung cancer metastasis, attenuate concentrations of proinflammatory cytokines (TNF-α, IL-17), and increase levels of immunosuppressive IL-10, nitric oxide, and kynurenine in sera of LLC1-treated mice. MSCs profoundly reduced infiltration of macrophages, TNF-α-producing dendritic cells (DCs), TNF-α-, and IL-17-producing CD4+ T cells but increased IL-10-producing CD4+ T lymphocytes in the lungs of tumor-bearing animals. The total number of lung-infiltrated, cytotoxic FasL, perforin-expressing, TNF-α-, and IL-17-producing CD8+ T lymphocytes, and NKG2D-expressing natural killer (NK) cells was significantly reduced in LLC1 + MSC-treated mice. Cytotoxicity of NK cells was suppressed by MSC-conditioned medium. This phenomenon was abrogated by the inhibitors of inducible nitric oxide synthase (iNOS) and indoleamine 2,3-dioxygenase (IDO), suggesting the importance of iNOS and IDO for MSC-mediated suppression of antitumor cytotoxicity of NK cells. This study provides the evidence that MSCs promote lung cancer metastasis by suppressing antitumor immune response raising concerns regarding safety of MSC-based therapy in patients who have genetic susceptibility for malignant diseases.Keywords
Funding Information
- Faculty of Medical Sciences, University of Kragujevac (MP01/12, MP01/14, ON175103, ON175069, IZ73Z0_152454/1)
- Faculty of Medical Sciences, University of Kragujevac (MP01/12, MP01/14, ON175103, ON175069, IZ73Z0_152454/1)
- Serbian Ministry of Science (MP01/12, MP01/14, ON175103, ON175069, IZ73Z0_152454/1)
- Serbian Ministry of Science (MP01/12, MP01/14, ON175103, ON175069, IZ73Z0_152454/1)
- Swiss National Science Foundation (MP01/12, MP01/14, ON175103, ON175069, IZ73Z0_152454/1)
- Phillip Morris and Center for Leadership Development (MP01/12, MP01/14, ON175103, ON175069, IZ73Z0_152454/1)
- Start Up for Science (MP01/12, MP01/14, ON175103, ON175069, IZ73Z0_152454/1)
This publication has 31 references indexed in Scilit:
- Human umbilical cord mesenchymal stem cells delivering sTRAIL home to lung cancer mediated by MCP-1/CCR2 axis and exhibit antitumor effectsTumor Biology, 2016
- Pulmonary Infection with Hypervirulent Mycobacteria Reveals a Crucial Role for the P2X7 Receptor in Aggressive Forms of TuberculosisPLOS Pathogens, 2014
- Mechanisms of tumor escape from immune system: Role of mesenchymal stromal cellsImmunology Letters, 2014
- Systemic Platelet-activating Factor Receptor Activation Augments Experimental Lung Tumor Growth and MetastasisCancer Growth and Metastasis, 2014
- Mesenchymal stem cells impair in vivo T-cell priming by dendritic cellsProceedings of the National Academy of Sciences, 2011
- Vascular endothelial growth factor-A and changes in a tumor-bearing mouse model with Lewis lung cancerOncology Letters, 2011
- Ability of IDO To Attenuate Liver Injury in α-Galactosylceramide–Induced Hepatitis ModelThe Journal of Immunology, 2010
- Reciprocal Interactions Between Human Mesenchymal Stem Cells and γδ T Cells Or Invariant Natural Killer T CellsStem Cells, 2009
- Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytesJournal of Leukocyte Biology, 2007
- Interactions Between Human Mesenchymal Stem Cells and Natural Killer CellsStem Cells, 2005